Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 23, Issue 5, 2005, Pages 322-326

  Kimura, Junko ^a   Ishiguchi, Tsuneo ^a   Matsuda, Joe ^a   Ohno, Ryota ^a   Nakamura, Atsushi ^a   Kamei, Seiji ^a   Ohno, Kazuko ^a   Kawamura, Toshiki ^a   Murata, Katsuhito ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Contrast agents; Copper; Gadolinium (Gd); MRI; Urine; Zinc

Indexed keywords

CONTRAST MEDIUM; COPPER; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOTERIC ACID; ZINC;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; HUMAN; IN VIVO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; URINALYSIS;

CONTRAST MEDIA; COPPER; FEMALE; GADOLINIUM DTPA; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; ZINC;

EID: 24644511256     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rocklage SM, Worah D, Kim SH. Metal ion release from paramagnetic chelates: what is tolerable? Magn Reson Med, 22: 216-221, 1991.
2. Puttagunta NR, Gibby WA, Smith GT. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Invest Radiol, 31: 739-742, 1996.
3. Prince MR, Erel HE, Lent RW, et al. Gadodiamide administration causes spurious hypocalcemia. Radiology, 227: 639-646, 2003.
4. Kasokat T, Urich K. Quantification of dechelation of gadopentetate dimeglumine in rats. Arzneimittelforschung, 42: 869-876, 1992.
5. Wedeking P, Kumar K, Tweedle MF. Dissociation of gadolinium chelates in mice: Relationship to chemical characteristics. Magn Reson Imaging, 10: 641-648, 1992.
6. Tweedle MF, Wedeking P, Kumar K. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Invest Radiol, 30: 372-380, 1995.
7. Molgo J, del Pozo E, Banos JE, Angaut-Petit D. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction. Br J Pharmacol, 104: 133-138, 1991.
8. Muhler A, Saeed M, Brasch RC, Higgins CB. Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium. Radiology, 184: 159-164, 1992.
9. Muhler A, Saeed M, Brasch RC, Higgins CB. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR Imaging in rats. Radiology, 183: 523-528, 1992.
10. Hattner RS, White DL. Gallium-67/stable gadolinium antagonism MRI contrast agent markedly alters the normal biodistribution of gallium-67. J Nucl Med, 31: 1844-1846, 1990.
11. Puttagunta NR, Gibby WA, Puttagunta VL. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media. Invest Radiol, 31: 619-624, 1996.
12. Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging, 8: 467-481, 1990.
13. Tweedle MF, Hagan JJ, Kumar K, Mantha S, Chag CA. Reaction of gadolinium chelates with endogenously available ions. Magn Reson Imaging, 9: 409-415, 1991.
14. Tweedle MF. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol, 27 (Suppl 1): S2-6, 1992.
15. Laurent S, Elst LV, Copoix F, Muller RN. Stability of MRI paramagnetic contrast media: a proton relaxometric protocol of transmetallation assessment. Invest Radiol, 36: 115-122, 2001.
16. Elster AD, Burdette J. Questions & answers in magnetic resonance imaging, 2nd ed. Mosby, Inc., St. Louis. 2001.
17. Tsuda N, Okumura M, Kato N, Yokokawa T. Effects of various MRI contrast agents on urinary excretion of zinc. NICHIDOKU-IHO, 47: 211-213,2002. (in Japanese with English abstract)
18. Kirchin MA, Runge VM. Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging, 14: 426-435, 2003.